Just Released: "Idiopathic (Essential) Hypertension - Pipeline Review, H2 2013"
Global Markets Direct's, 'Idiopathic (Essential) Hypertension - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Idiopathic (Essential) Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Idiopathic (Essential) Hypertension. Idiopathic (Essential) Hypertension - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release